Dover Corporation
DOV NYSEIndustrials ★★★★★Latest Earnings
Date
Jul 23, 2026
ET
EPS Est.
2.72
EPS Actual
2.74
Revenue Est.
$2.21B
Revenue Actual
$2.19B
Next Earnings Report Date unconfirmed
Date
Oct 22, 2026 · Thu
Time
Time TBD
Fiscal Period
--
EPS Est.
2.86
Revenue Est.
$2.21B
Company Overview
Dover Corporation (ticker DOV) is listed on NYSE with a market cap of about $27.19B. Its next earnings report is expected on Oct 22, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of 2.86. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Jan 31, 2023 → Jul 23, 2026
Jan 31, 2023Range: 1.94 ~ 2.74Jul 23, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 23, 2026 | -- | 2.72 | 2.74 | $2.21B | $2.19B |
| Apr 23, 2026 | -- | 2.27 | 2.28 | $2B | $2.05B |
| Jan 29, 2026 | -- | 2.49 | 2.51 | $2.09B | $2.1B |
| Oct 23, 2025 | -- | 2.51 | 2.62 | $2.11B | $2.08B |
| Jul 24, 2025 | -- | 2.39 | 2.44 | $2.04B | $2.05B |
| Apr 24, 2025 | -- | 1.98 | 2.05 | $1.88B | $1.87B |
| Jan 30, 2025 | -- | 2.20 | 2.20 | $1.95B | $1.93B |
| Oct 24, 2024 | -- | 2.30 | 2.27 | $2.02B | $1.98B |
| Jul 25, 2024 | -- | 2.21 | 2.36 | $2.15B | $2.18B |
| Apr 25, 2024 | -- | 1.87 | 1.95 | $2.03B | $2.09B |
| Feb 1, 2024 | -- | 2.42 | 2.45 | $2.16B | $2.11B |
| Oct 24, 2023 | -- | 2.32 | 2.35 | $2.22B | $2.15B |
| Jul 25, 2023 | -- | 2.20 | 2.05 | $2.2B | $2.1B |
| Apr 26, 2023 | -- | 1.92 | 1.94 | $2.07B | $2.08B |
| Jan 31, 2023 | -- | 2.15 | 2.16 | $2.12B | $2.14B |
Original Filings (SEC)
10-Q2026-07-23 ↗
8-K2026-07-23 ↗
8-K2026-05-12 ↗
10-Q2026-04-23 ↗
8-K2026-04-23 ↗
8-K2026-04-08 ↗
10-K2026-02-13 ↗
8-K2026-01-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
